Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS
MAGLUMI Lp-PLA2 (CLIA) MAGLUMI Lp-PLA2 (CLIA) MAGLUMI Lp-PLA2 (CLIA) MAGLUMI Lp-PLA2 (CLIA)
MAGLUMI Lp-PLA2 (CLIA)
MAGLUMI Lp-PLA2 (CLIA) MAGLUMI Lp-PLA2 (CLIA) MAGLUMI Lp-PLA2 (CLIA)

MAGLUMI Lp-PLA2 (CLIA)

1.0 INR/Unit

Product Details:

  • Instruments Type CLIA
  • Storage Instructions 2 to 8 degree
  • Equipment Type For use with MAGLUMI CLIA analyzers
  • Usage Type Laboratory
  • Condition New
  • Technology chemiluminescence immunoassay
  • Real-Time Operation Yes
  • Click to View more
X

MAGLUMI Lp-PLA2 (CLIA) Price And Quantity

  • 1.0 INR/Unit
  • As per company policy Unit

MAGLUMI Lp-PLA2 (CLIA) Product Specifications

  • Yes
  • For use with MAGLUMI CLIA analyzers
  • New
  • 2 to 8 degree
  • chemiluminescence immunoassay
  • CLIA
  • Laboratory

Product Description

Brand Snibe
Sample Type Serum
Pack Size 100T
CAT No. 130206515M
Application Cardiac Marker
The kit has been designed for the quantitative determination of Lipoprotein-associated Phospholipase A2 (Lp-PLA2) in human serum or plasma. The method can be used for samples within a measuring range of 20600 ng/mL. The test is performed on fully automated MAGLUMI chemiluminescence immunoassay (CLIA) analyzers, including MAGLUMI 800, MAGLUMI X8, and other MAGLUMI models such as MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, and MAGLUMI 4000.

Advanced Cardiovascular Risk Assessment

The MAGLUMI Lp-PLA2 (CLIA) offers laboratories a cutting-edge tool for evaluating cardiovascular disease risks using chemiluminescent immunoassay technology. Its real-time operational design ensures rapid, precise results for patient care.


Seamless Laboratory Integration

Compatible solely with MAGLUMI CLIA analyzers, this reagent kit integrates smoothly into automated laboratory workflows. Designed for new installations, it meets the highest standards required by diagnostic professionals.

FAQ's of MAGLUMI Lp-PLA2 (CLIA):


Q: How is the MAGLUMI Lp-PLA2 (CLIA) reagent kit used in a laboratory setting?

A: The MAGLUMI Lp-PLA2 (CLIA) reagent kit is intended for use with MAGLUMI CLIA analyzers in clinical laboratories. Technicians load samples and reagents onto the analyzer, which then performs the chemiluminescence immunoassay to quantify Lp-PLA2 levels in real time.

Q: What are the benefits of using chemiluminescence immunoassay (CLIA) technology for Lp-PLA2 detection?

A: CLIA technology offers enhanced sensitivity, specificity, and faster turnaround compared to traditional methods, allowing timely and accurate assessment of cardiovascular risk with minimal manual intervention.

Q: When should the MAGLUMI Lp-PLA2 (CLIA) assay be performed?

A: This assay is typically performed when a physician requires precise evaluation of a patient's cardiovascular risk, especially in screening or monitoring situations in clinical laboratories.

Q: Where should the MAGLUMI Lp-PLA2 (CLIA) reagent kits be stored?

A: To maintain reagent stability and integrity, the kit should be stored in a dedicated laboratory refrigerator at temperatures between 2C and 8C, away from direct sunlight and exposure to extreme temperatures.

Q: What is the process for obtaining the MAGLUMI Lp-PLA2 (CLIA) reagent kit in India?

A: You can source the reagent kit through authorized dealers, distributors, manufacturers, exporters, suppliers, traders, or wholesalers throughout India, ensuring you select a reliable partner for prompt and secure delivery.

Q: Who can use or distribute the MAGLUMI Lp-PLA2 (CLIA) reagent kit?

A: This product is intended for use or distribution by certified laboratory professionals, dealers, distributors, manufacturers, and related entities in the scientific or medical diagnostic sector.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical CLIA' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.